Department of Cardiothoracic Surgery, Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, China.
Department of Cardiothoracic Surgery, First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, China.
Biomed Res Int. 2020 Nov 25;2020:8838524. doi: 10.1155/2020/8838524. eCollection 2020.
Ischemia-reperfusion injury (IRI) elicits tissue injury involved in a wide range of pathologies. Multiple studies have demonstrated that noncoding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), participate in the pathological development of IRI, and they may act as biomarkers, therapeutic targets, or prognostic indicators. Nonetheless, the specific molecular mechanisms of ncRNAs in IRI have not been completely elucidated. Regulatory networks among lncRNAs/circRNAs, miRNAs, and mRNAs have been the focus of attention in recent years. Studies on the underlying molecular mechanisms have contributed to the discovery of therapeutic targets or strategies in IRI. In this review, we comprehensively summarize the current research on the lncRNA/circRNA-miRNA-mRNA axes and highlight the important role of these axes in IRI.
缺血再灌注损伤(IRI)引起涉及多种病理的组织损伤。多项研究表明,非编码 RNA(ncRNA),包括长非编码 RNA(lncRNA)、环状 RNA(circRNA)和 microRNA(miRNA),参与 IRI 的病理发展,它们可能作为生物标志物、治疗靶点或预后指标。尽管如此,ncRNA 在 IRI 中的具体分子机制尚未完全阐明。lncRNA/circRNA、miRNA 和 mRNA 之间的调控网络是近年来的研究焦点。对潜在分子机制的研究有助于发现 IRI 的治疗靶点或策略。在这篇综述中,我们全面总结了 lncRNA/circRNA-miRNA-mRNA 轴的最新研究进展,并强调了这些轴在 IRI 中的重要作用。